Pregled bibliografske jedinice broj: 1152458
A Novel SETBP1 Gene Disruption by a De Novo Balanced Translocation in a Patient with Speech Impairment, Intellectual, and Behavioral Disorder
A Novel SETBP1 Gene Disruption by a De Novo Balanced Translocation in a Patient with Speech Impairment, Intellectual, and Behavioral Disorder // Journal of Pediatric Genetics, q4 (2020), 10.1055/s-0040-1715639, 4 doi:10.1055/s-0040-1715639 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1152458 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
A Novel SETBP1 Gene Disruption by a De Novo
Balanced Translocation in a Patient with Speech
Impairment, Intellectual, and Behavioral Disorder
Autori
Vrkic Boban, Ivona ; Sekiguchi, Futoshi ; Lozic, Mirela ; Miyake, Noriko ; Matsumoto, Naomichi ; Lozic, Bernarda
Izvornik
Journal of Pediatric Genetics (2146-4596) Q4
(2020);
10.1055/s-0040-1715639, 4
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
balanced chromosomal abnormalities, whole genome sequencing, SETBP1
Sažetak
Balanced chromosomal abnormalities (BCAs) can disrupt gene function resulting in disease. To date, BCA disrupting the SET binding protein 1 (SETBP1) gene has not been reported. On the other hand, de novo heterozygous variants in the highly conserved 11-bp region in SETBP1 can result in the Schinzel–Giedion syndrome. This condition is characterized by severe intellectual disability, a characteristic face, and multiple-system anomalies. Further other types of mutations involving SETBP1 are associated with a different phenotype, mental retardation, autosomal dominant 29 (MRD29), which has mild dysmorphic features, developmental delay, and behavioral disorders. Here we report a male patient who has moderate intellectual disability, mild behavioral difficulties, and severe expressive speech impairment resulting from a de novo balanced chromosome translocation, t(12 ; 18)(q22 ; q12.3). By whole genome sequencing, we determined the breakpoints at the nucleotide level. The 18q12.3 breakpoint was located between exons 2 and 3 of SETBP1. Phenotypic features of our patient are compatible with those with MRD29. This is the first reported BCA disrupting SETBP1.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC Split,
Medicinski fakultet, Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Emerging Sources Citation Index (ESCI)
- Scopus